Dr Ashish Kumar is a Professor and Senior Consultant of Gastroenterology at Sir Ganga Ram Hospital, New Delhi, India. He completed his Gastroenterology training from the Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India in 2004. Subsequently, he worked under the mentorship of Prof Shiv Kumar Sarin for 5 years in his unit in various capacities including at the Institute of Liver & Biliary Sciences (ILBS), New Delhi, India. He has been a visiting fellow at the National Cancer Center, Japan and the University of California, San Francisco, USA. He is a Fellow of the American College of Physicians (FACP) and the Member in the Advisory Council, American College of Physicians (ACP), India Chapter, and the Associate Editor of the Journal of Clinical and Experimental Hepatology. In 2021 and 2022, he was named as one among the top 2% scientists in the world by Elsevier and the Stanford University. He has over 190 publications mostly in international journals, including Gastroenterology, Annals of Internal Medicine, and Gut. His research areas include mainly hepatocellular carcinoma, portal hypertension, acute-on-chronic-liver failure, and stem cells for liver diseases. He is the coordinator and the lead author of the Indian Consensus on Treatment of Liver Cancer under the aegis of Indian National Association for the Study of the Liver (INASL). He has been a Governing Council Member of the INASL and Taskforce member on Hepatitis B and was instrumental in publishing various INASL Guidelines. He was also a faculty member of the Baveno working group on portal hypertension, and member of many APASL working groups. His paper on HVPG-Fibroscan correlation was awarded the Best Paper Award by the GRIPMER and his paper on GI manifestations of Covid was awarded the Best Original Article Award by the Indian Journal of Gastroenterology. ACP has awarded him the ACP India Chapter Clinical Practice Award for the year 2021 and the Scientist of the Year Award for the year 2022. He has also received the India International Healthcare Award for being The Most Promising Gastroenterologist of the Year 2018 of Delhi.
1. Arora A, Kumar A, Anand AC, Kumar A, Yadav A, Bhagwat A, Mullasari AS, Satwik A, Saraya A, Mehta A, Roy D, Reddy DN, Makharia G, Murthy JMK, Roy J, Sawhney JPS, Prasad K, Goenka M, Philip M, Umaiorubahan M, Sinha N, Mohanan PP, Sylaja PN, Ramakrishna P, Kerkar P, Rai P, Kochhar R, Yadav R, Nijhawan S, Sinha SK, Hastak SM, Viswanathan S, Ghoshal UC, Madathipat U, Thakore V, Dhir V, Saraswat VA, Nabi Z. Position statement from the Indian Society of Gastroenterology, Cardiological Society of India, Indian Academy of Neurology and Vascular Society of India on gastrointestinal bleeding and endoscopic procedures in patients on antiplatelet and/or anticoagulant therapy. Indian J Gastroenterol. 2023 Jun 5. doi: 10.1007/s12664-022-01324-6. Epub ahead of print. PMID: 37273146. (PubMed)
2. Maiwall R, Pasupuleti SSR, Choudhury A, Kim DJ, Sood A, Goyal O, Midha V, Devarbhavi H, Arora A, Kumar A, Sahu MK, Maharshi S, Duseja AK, Singh V, Taneja S, Rao PN, Kulkarni A, Ghazinian H, Hamid S, Eapen CE, Goel A, Shreshtha A, Shah S, Hu J, Prasad VGM, Yuemin N, Shaojie X, Dhiman RK, Chen T, Ning Q, Panackel C, Niriella MA, Lama TK, Tan SS, Dokmeci AK, Shukla A, Sharma MK, Sarin SK. AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study. Hepatol Int. 2022 Dec 26. doi: 10.1007/s12072-022-10463-z. Epub ahead of print. PMID: 36571711.
3. Srivastava S, Kumar A, Maheshwari A, Kapse G. Proposed survey questionnaire for the diagnosis of irritable bowel syndrome: Based on patient complaints. Int J Adv Res Ideas Innov Technol. 2023;9(2):44-47.
4. Duseja A, Singh SP, De A, Madan K, Rao PN, Shukla A, Choudhuri G, Saigal S, Shalimar, Arora A, Anand AC, Das A, Kumar A, Eapen CE, Devadas K, Shenoy KT, Panigrahi M, Wadhawan M, Rathi M, Kumar M, Choudhary NS, Saraf N, Nath P, Kar S, Alam S, Shah S, Nijhawan S, Acharya SK, Aggarwal V, Saraswat VA, Chawla YK. Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD). J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7. PMID: 36950481; PMCID: PMC10025685.
5. Anikhindi S, Anikhindi A, Kumar A, Arora A. A Review on "IL-1 Receptor Antagonist Plus Pentoxifylline and Zinc for Severe Alcohol-Associated Hepatitis". J Clin Exp Hepatol. 2023 May-Jun;13(3):533-535. doi: 10.1016/j.jceh.2023.01.011. Epub 2023 May 18. PMID: 37250885; PMCID: PMC10213870.
6. Kumar A. Making Sense of the Antisense Therapy for Hepatitis B - Bepirovirsen. J Clin Exp Hepatol. 2023 May-Jun;13(3):535-537. doi: 10.1016/j.jceh.2022.12.013. Epub 2023 May 18. PMID: 37250875; PMCID: PMC10213862.
7. Kumar A. Will Tirzepatide Become a Game-Changer Anti-Obesity Drug? J Clin Exp Hepatol. 2023 May-Jun;13(3):532-533. doi: 10.1016/j.jceh.2023.01.012. Epub 2023 May 18. PMID: 37250871; PMCID: PMC10213833.
8. Kumar A. Hepatic Dysfunction in Kidney Transplant Recipients. In: Bhargava V, Sahay M, Meena P, Sakhuja V, Gupta A, eds. Textbook of Kidney Transplantation. First edition. Jaypee Brothers Medical Publishers; 2023:269-274.
9. Kumar A, Maruyama H, Arora A, Sharma P, Anikhindi SA, Bansal N, Kumar M, Ranjan P, Sachdeva M, Khare S. Diagnostic accuracy of transient elastography in diagnosing clinically significant portal hypertension in patients with chronic liver disease: a systematic review and meta-analysis. J Med Ultrason (2001). 2022 Jul;49(3):333-346. doi: 10.1007/s10396-022-01239-x. Epub 2022 Jul 25. PMID: 35876975.
10. Arora A, Singal A, Sharma P, Kumar A. A proposed five-step simplified algorithm for the management of hepatocellular carcinoma in India. Curr Med Res Pract. 2022, 12:224. 10.4103/cmrp.cmrp_69_22.
11. Padole P, Arora A, Sharma P, Chand P, Verma N, Kumar A. Saroglitazar for Nonalcoholic Fatty Liver Disease: A Single Centre Experience in 91 Patients. J Clin Exp Hepatol. 2022 Mar-Apr;12(2):435-439. doi: 10.1016/j.jceh.2021.06.015. Epub 2021 Jun 19. PMID: 35535066; PMCID: PMC9077151.
12. Singla V, Arora A, Rana SS, Kohle M, Khare S, Kumar A, Bansal N, Sharma P. EUS-Guided Rendezvous and Tractogastrostomy: A Novel Technique for Disconnected Pancreatic Duct Syndrome with External Pancreatic Fistula. J Dig Endosc 2022; 13(03): 129-135. DOI: 10.1055/s-0042-1754334.
13. Kumar A, Sharma P, Arora A. Letter to the editor: In patients with established NASH cirrhosis, is there no role of weight reduction in reversing fibrosis? Hepatology. 2022 Jul;76(1):E3-E4. doi: 10.1002/hep.32375. Epub 2022 Feb 15. PMID: 35092319.
14. Kumar A. Alcohol-related Liver Disease. In: Kamath SA, ed. API Textbook of Medicine. Vol 2. 12th ed. Jaypee Brothers Medical Publishers; 2022:1599-1607.
